845
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

A Regulatory Perspective on Essential Considerations in Design and Analysis of Subgroups When Correctly Classified

&
Pages 19-41 | Received 09 Aug 2013, Accepted 28 Aug 2013, Published online: 06 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ilya Lipkovich, Alex Dmitrienko, Christoph Muysers & Bohdana Ratitch. (2018) Multiplicity issues in exploratory subgroup analysis. Journal of Biopharmaceutical Statistics 28:1, pages 63-81.
Read now
Toshimitsu Hamasaki, Scott R. Evans & Koko Asakura. (2018) Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review. Journal of Biopharmaceutical Statistics 28:1, pages 28-51.
Read now
Alex Dmitrienko, Christoph Muysers, Arno Fritsch & Ilya Lipkovich. (2016) General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trials. Journal of Biopharmaceutical Statistics 26:1, pages 71-98.
Read now

Articles from other publishers (18)

Cynthia Huber, Tim Friede, Julia Stingl & Norbert Benda. (2021) Classification of Companion Diagnostics: A New Framework for Biomarker-Driven Patient Selection. Therapeutic Innovation & Regulatory Science 56:2, pages 244-254.
Crossref
Wanying Zhao, Wei Ma, Fan Wang & Feifang Hu. (2021) Incorporating covariates information in adaptive clinical trials for precision medicine. Pharmaceutical Statistics 21:1, pages 176-195.
Crossref
Matthew Plow, Tanya Packer, Virgil G. Mathiowetz, Kathy Preissner, Setareh Ghahari, Abdus Sattar, Francois Bethoux & Marcia Finlayson. (2020) REFRESH protocol: a non-inferiority randomised clinical trial comparing internet and teleconference to in-person ‘Managing Fatigue’ interventions on the impact of fatigue among persons with multiple sclerosis. BMJ Open 10:8, pages e035470.
Crossref
Alex Dmitrienko, Ilya Lipkovich, Aaron Dane & Christoph Muysers. 2020. Design and Analysis of Subgroups with Biopharmaceutical Applications. Design and Analysis of Subgroups with Biopharmaceutical Applications 33 91 .
Stefan Schandelmaier, Yaping Chang, Niveditha Devasenapathy, Tahira Devji, Joey S.W. Kwong, Luis E. Colunga Lozano, Yung Lee, Arnav Agarwal, Neera Bhatnagar, Hannah Ewald, Ying Zhang, Xin Sun, Lehana Thabane, Michael Walsh, Matthias Briel & Gordon H. Guyatt. (2019) A systematic survey identified 36 criteria for assessing effect modification claims in randomized trials or meta-analyses. Journal of Clinical Epidemiology 113, pages 159-167.
Crossref
Stan R W Wijn, Maroeska M Rovers, Ly H Le, Michail Belias, Jeroen Hoogland, Joanna IntHout, Thomas Debray & Johannes B Reitsma. (2019) Guidance from key organisations on exploring, confirming and interpreting subgroup effects of medical treatments: a scoping review. BMJ Open 9:8, pages e028751.
Crossref
Demissie Alemayehu, Yang Chen & Marianthi Markatou. (2017) A comparative study of subgroup identification methods for differential treatment effect: Performance metrics and recommendations. Statistical Methods in Medical Research 27:12, pages 3658-3678.
Crossref
Un Jung Lee, ShengLi Tzeng, Yu-Chuan Chen & James J Chen. (2018) Prognostic and predictive signatures for treatment decisions. Biomarkers in Medicine 12:8, pages 849-859.
Crossref
H. M. James Hung, Xiangmin Zhang & Sue-Jane Wang. (2017) Some Recent Advances on Statistical Approaches for Planning Multi-regional Clinical Trials. Statistics in Biosciences 10:2, pages 460-472.
Crossref
Yu-Chuan Chen, Un Jung Lee, Chen-An Tsai & James J. Chen. (2018) Development of predictive signatures for treatment selection in precision medicine with survival outcomes. Pharmaceutical Statistics 17:2, pages 105-116.
Crossref
Alex Dmitrienko, Brian MillenIlya Lipkovich. (2017) Multiplicity considerations in subgroup analysis. Statistics in Medicine 36:28, pages 4446-4454.
Crossref
Mohamed AloshMohammad F. HuqueFrank Bretz & Ralph B. D'AgostinoSr.Sr.. (2017) Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials. Statistics in Medicine 36:8, pages 1334-1360.
Crossref
Julien Tanniou, Ingeborg van der Tweel, Steven Teerenstra & Kit C. B. Roes. (2016) Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes. BMC Medical Research Methodology 16:1.
Crossref
Ying DingHui-Min LinJason C. Hsu. (2016) Subgroup mixable inference on treatment efficacy in mixture populations, with an application to time-to-event outcomes. Statistics in Medicine 35:10, pages 1580-1594.
Crossref
Lindsay A. Renfro, Himel Mallick, Ming-Wen An, Daniel J. Sargent & Sumithra J. Mandrekar. (2016) Clinical trial designs incorporating predictive biomarkers. Cancer Treatment Reviews 43, pages 74-82.
Crossref
Toshimitsu Hamasaki, Koko Asakura, Scott R. Evans & Toshimitsu OchiaiToshimitsu Hamasaki, Koko Asakura, Scott R. Evans & Toshimitsu Ochiai. 2016. Group-Sequential Clinical Trials with Multiple Co-Objectives. Group-Sequential Clinical Trials with Multiple Co-Objectives 97 102 .
Tzu-Pin Lu & James J. Chen. (2015) Identification of drug-induced toxicity biomarkers for treatment determination. Pharmaceutical Statistics 14:4, pages 284-293.
Crossref
Sue-Jane Wang & H.M. James Hung. (2013) Adaptive enrichment with subpopulation selection at interim: Methodologies, applications and design considerations. Contemporary Clinical Trials 36:2, pages 673-681.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.